George Sellers
Stock Analyst at Stephens & Co.
(0.84)
# 2,890
Out of 4,479 analysts
52
Total ratings
26.19%
Success rate
-21.74%
Average return
Main Sectors:
12 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CUTR Cutera | Reiterates: Overweight | $10 | $1.50 | +566.67% | 10 | Jun 25, 2024 | |
| TMDX TransMedics Group | Initiates: Overweight | $151 | $150.19 | +0.54% | 1 | Jun 4, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $25.85 | -7.16% | 6 | May 29, 2024 | |
| FNA Paragon 28 | Reiterates: Overweight | $18 | $6.58 | +173.56% | 3 | Apr 5, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $44.35 | +62.34% | 1 | Feb 13, 2024 | |
| ESTA Establishment Labs Holdings | Reiterates: Overweight | $47 | $43.34 | +8.44% | 6 | Jan 11, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $1.30 | +284.62% | 2 | Nov 10, 2023 | |
| TFX Teleflex | Reiterates: Overweight | $275 | $211.44 | +30.06% | 8 | Nov 3, 2023 | |
| VCEL Vericel | Reiterates: Overweight | $44 | $45.03 | -2.29% | 1 | Sep 21, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $6.49 | +285.21% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $47.42 | +20.20% | 6 | Aug 14, 2023 | |
| GKOS Glaukos | Reiterates: Overweight | $71 | $117.42 | -39.53% | 4 | May 8, 2023 |
Cutera
Jun 25, 2024
Reiterates: Overweight
Price Target: $10
Current: $1.50
Upside: +566.67%
TransMedics Group
Jun 4, 2024
Initiates: Overweight
Price Target: $151
Current: $150.19
Upside: +0.54%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $25.85
Upside: -7.16%
Paragon 28
Apr 5, 2024
Reiterates: Overweight
Price Target: $18
Current: $6.58
Upside: +173.56%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $44.35
Upside: +62.34%
Establishment Labs Holdings
Jan 11, 2024
Reiterates: Overweight
Price Target: $47
Current: $43.34
Upside: +8.44%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $1.30
Upside: +284.62%
Teleflex
Nov 3, 2023
Reiterates: Overweight
Price Target: $275
Current: $211.44
Upside: +30.06%
Vericel
Sep 21, 2023
Reiterates: Overweight
Price Target: $44
Current: $45.03
Upside: -2.29%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $6.49
Upside: +285.21%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $47.42
Upside: +20.20%
Glaukos
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $117.42
Upside: -39.53%